Neonatal withdrawal following pre- and postnatal exposure to methadone in the rat. 1998

G A Barr, and A Zmitrovich, and A S Hamowy, and P Y Liu, and S Wang, and D E Hutchings
Department of Developmental Psychobiology, New York State Psychiatric Institute, New York 10032, USA.

Recent evidence has shown that infant rats undergo precipitated withdrawal following chronic postnatal injection of morphine. In this study we examined whether or not infants exposed to methadone prenatally via the placental blood supply and postnatally via the dam's milk would also experience precipitated withdrawal. Dam's were implanted on gestational day 14 with osmotic minipumps containing one of two concentrations of methadone to supply the opiate throughout gestation and the first postnatal week. Nontreated and pair-fed controls were used. On postnatal day 7, pups were injected with naltrexone and their locomotor activity and ultrasonic vocalizations measured. Methadone exposed pups were more active and vocalized more when injected with naltrexone than with saline. The controls did not show these behavioral changes. The milk of methadone-exposed dams apparently contains sufficient quantities of the opiate for dependence to develop. The results are consistent with other data that demonstrate that very young rat pups can experience an opiate abstinence syndrome that includes increased behavioral activation.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008691 Methadone A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3) Amidone,Biodone,Dolophine,Metadol,Metasedin,Methaddict,Methadone Hydrochloride,Methadose,Methex,Phenadone,Phymet,Physeptone,Pinadone,Symoron,Hydrochloride, Methadone
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D009357 Neonatal Abstinence Syndrome Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances. Abstinence Syndrome, Neonatal,Neonatal Withdrawal Syndrome,Passive Addiction, Neonatal,Substance Withdrawal, Neonatal,Neonatal Substance Withdrawal,Abstinence Syndromes, Neonatal,Addiction, Neonatal Passive,Addictions, Neonatal Passive,Neonatal Abstinence Syndromes,Neonatal Passive Addiction,Neonatal Passive Addictions,Neonatal Substance Withdrawals,Neonatal Withdrawal Syndromes,Passive Addictions, Neonatal,Substance Withdrawals, Neonatal,Syndrome, Neonatal Abstinence,Syndrome, Neonatal Withdrawal,Syndromes, Neonatal Abstinence,Syndromes, Neonatal Withdrawal,Withdrawal Syndrome, Neonatal,Withdrawal Syndromes, Neonatal,Withdrawal, Neonatal Substance
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G A Barr, and A Zmitrovich, and A S Hamowy, and P Y Liu, and S Wang, and D E Hutchings
January 1982, Neurobehavioral toxicology and teratology,
G A Barr, and A Zmitrovich, and A S Hamowy, and P Y Liu, and S Wang, and D E Hutchings
February 2010, Acta paediatrica (Oslo, Norway : 1992),
G A Barr, and A Zmitrovich, and A S Hamowy, and P Y Liu, and S Wang, and D E Hutchings
January 1988, Acta physiologica et pharmacologica Bulgarica,
G A Barr, and A Zmitrovich, and A S Hamowy, and P Y Liu, and S Wang, and D E Hutchings
January 1996, The Journal of maternal-fetal medicine,
G A Barr, and A Zmitrovich, and A S Hamowy, and P Y Liu, and S Wang, and D E Hutchings
January 2024, Pharmacotherapy,
G A Barr, and A Zmitrovich, and A S Hamowy, and P Y Liu, and S Wang, and D E Hutchings
April 1991, Journal of paediatrics and child health,
G A Barr, and A Zmitrovich, and A S Hamowy, and P Y Liu, and S Wang, and D E Hutchings
January 1987, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement,
G A Barr, and A Zmitrovich, and A S Hamowy, and P Y Liu, and S Wang, and D E Hutchings
January 1989, Anatomischer Anzeiger,
G A Barr, and A Zmitrovich, and A S Hamowy, and P Y Liu, and S Wang, and D E Hutchings
January 2022, Journal of pediatric rehabilitation medicine,
G A Barr, and A Zmitrovich, and A S Hamowy, and P Y Liu, and S Wang, and D E Hutchings
January 1979, Neurobehavioral toxicology,
Copied contents to your clipboard!